Q1 saw robust retail health growth (46.5%), improved profitability, and higher market share, with strong digital and operational execution. Expense and loss ratios improved, and guidance remains for above-market retail growth and stable margins.Based on Niva Bupa Health Insurance Company Limited [N…
Q1 FY27 saw robust growth, with retail health up 47.1% and profit after tax at INR 137.8 crore. Key ratios improved, expense management strengthened, and the company expects to sustain growth above market rates, with ROE guided to mid-high teens by FY29.Based on Niva Bupa Health Insurance Company L…
Insurance revenue and profit grew strongly year-over-year, with Q1 FY27 profit after tax at ₹13,780 lakhs and gross written premium at ₹214,996 lakhs. The Board approved raising up to ₹500 crore via debentures, and solvency remains robust at 2.25.Original document: Niva Bupa Health Insurance Compan…
